Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant Human soluble Fc-gamma Receptor IIb |
---|---|
Date Designated: | 03/22/2010 |
Orphan Designation: | Treatment of idiopathic thrombocytopenic purpura |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/27/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Baxalta US Inc., now part of Shire Plc 650 Kendall Street Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-